The Lynx Group

Patrick Forde, MD


Director, Thoracic Oncology Clinical Research Program
Associate Professor of Oncology
Johns Hopkins University School of Medicine
Baltimore, MD

Authored Items

Multiple Pathways and Resources for NSCLC Treatment in an Academic Medical Center

Stakeholder Perspective

In my medical oncology practice at Johns Hopkins, I see approximately 4 patients with nonmetastatic NSCLC per week. Most of these patients are referrals from either pulmonary medicine or thoracic surgery. A patient with early stage disease initially sees a pulmonologist for diagnosis and may then be referred to a thoracic surgeon. The thoracic surgeon may refer the patient to us in medical oncology if there is an indication to enroll the patient in a clinical trial or for systemic therapy. In a community oncology practice, patients tend to go to surgery first and are then referred to the medical oncologist for adjuvant chemotherapy. In academic centers, it is more common for patients to be seen in a multidisciplinary setting.

Sign me up!